TNFRSF8 and anaplastic large cell lymphoma: Tissue biopsy samples obtained from patients with anaplastic large cell lymphoma (ALCL) treated with brentuximab vedotin at the time they relapsed or progressed showed varied expression of CD30 on ALCL cells [104].